Unknown

Dataset Information

0

Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline.


ABSTRACT:

SUBMITTER: Chedid V 

PROVIDER: S-EPMC5816691 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline.

Chedid Victor V   Vijayvargiya Priya P   Camilleri Michael M  

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20171116 3


Similar Datasets

| S-EPMC8213312 | biostudies-literature
| S-EPMC5946322 | biostudies-other
| S-EPMC10401141 | biostudies-literature
| S-EPMC11335658 | biostudies-literature
| S-EPMC11743753 | biostudies-literature
| S-EPMC9631444 | biostudies-literature
| S-EPMC11324990 | biostudies-literature
| S-EPMC7571929 | biostudies-literature
| S-EPMC11263116 | biostudies-literature
| S-EPMC11760955 | biostudies-literature